SwissTAVI

Swiss national cohort study investigating transcatheter aortic valve replacement - NCT01368250

[Bashir Alaour @BashirAlaour]

Bleeding After Transcatheter Aortic Valve Replacement: The Pebble and the Ripple"
Sharing our recently published editorial @JACCJournals
@StefanStortecky

https://t.co/SBp7UkD89i

[Bashir Alaour @BashirAlaour]

1/2 "Compared to age- and sex-matched population, TAVR patients exhibit higher risk of stroke for up to two years post TAVR"
Delighted to share our work from the SwissTAVI registry
@StefanStortecky @taishiokuno @ThomPilgrim @SwissTavi @JACCJournals https://t.co/gMIGs2oGRK

[Stefan Stortecky @StefanStortecky]

@JAHA_AHA; @ThomPilgrim; @DanielHagemeyer; @chrisgraeni; @SwissTavi

[JAHA @JAHA_AHA]

Clinical Outcomes in High‐Gradient, Classical Low‐Flow, Low‐Gradient, and Paradoxical Low‐Flow, Low‐Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation. #AHAJournals @WagenerM1 @StToggweiler @StefanStortecky https://t.co/XVbZhFyIO0

[European Society of Cardiology @escardio]

ESC TV On the Road 🚍 at #ACC23 Watch

Stephan Windecker as he shares the 3-year outcomes from the Evolut Low Risk Trial

[Stefan Stortecky @StefanStortecky]

Enterococcal colonization of the groin and isolation of enterococci in TAVR-associated IE --> a change in antimicrobial prophylaxis is warranted and should be changed to antimicrobial prophylaxis with a compound that is active against enterococci.

https://t.co/N8zOiQsc2e

[Thomas Pilgrim @ThomPilgrim]

In the SCOPE I trial, early differences in procedural outcomes and valve performance between the ACURATE neo and SAPIEN 3 THVs did not translate into differences in clinical outcomes or bioprosthetic valve failure at 3 years in an elderly population at intermediate surgical risk.

[Stefan Stortecky @StefanStortecky]

Surgery After TAVR: Waiting a Month or More Not Really Better - data from BernTAVI @SwissTavi
https://t.co/9Icy3t362f

[Stefan Stortecky @StefanStortecky]

Rates, predictors, and prognostic impact of immediate technical success (VARC-3) - insights from BernTAVI

Technical failure was associated with a 2-fold increased risk of the composite outcome at 1 year Fup.

From @jaccjournals https://t.co/HvddH0UHjN

[SwissTAVI @SwissTavi]

Infective endocarditis after TAVR: 4 key findings from a new study of 7,000 patients @SwissTAVI https://t.co/ZYeeKTV9Ij

[SwissTAVI @SwissTavi]

@StefanStortecky @JACCJournals
- highest risk of infective endocarditis after TAVR during the early peri-procedural phase
- carefully select your antibiotic prophylaxis among TF TAVR patients
- invest in surgical-like preventive hygiene measures

[Stefan Stortecky @StefanStortecky]

Analysis from @SwissTAVI - infective endocarditis frequently incurs early after TAVR, is commonly caused by Enterococcus species and results in considerable risks of mortality and stroke.
@JACCJournals
https://t.co/sqa35OLTL0